H. Lundbeck, Cipralex® superior to Paxil® in treating social anxiety disorder

New data released today confirms that Cipralex® (escitalopram) is significantly superior to placebo in the treatment of social anxiety disorder (SAD). At 24 weeks, Cipralex® also showed a significantly superior effect compared to Paxil® (paroxetine) in the treatment of SAD. In addition, Cipralex® showed superior results compared to placebo in preventing relapse and proved to be an excellently tolerated treatment for SAD.